Close

Immune Design's (IMDZ) GLAAS Discovery Platform Utilized in Sanofi Phase 1 for Peanut Allergy Therapy

Go back to Immune Design's (IMDZ) GLAAS Discovery Platform Utilized in Sanofi Phase 1 for Peanut Allergy Therapy